Business
Creso Pharma and LGC Capital Announce Strategic Alliance
Creso Pharma and LGC Capital Announce Strategic Alliance Canada NewsWire MONTREA...
About this update from Elixxer Ltd.
[{"type":"text","content":"\n\n\n\nCreso Pharma and LGC Capital Announce Strategic Alliance\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTREAL and PERTH, Australia, Nov. 9, 2017\n\n\n\nMONTREAL and PERTH, Australia, Nov. 9, 2017 /CNW Telbec/ - Creso Pharma (\"Creso\"), the Australian listed and Swiss based pharmaceutical company, and Canadian listed LGC Capital Ltd. (\"LGC\"), jointly announce the formation of a new and exciting strategic alliance intended to create a vertically-integrated cannabis operation with a global footprint spanning cultivation, IP generation, innovative product development and commercialisation.\n\n\nIn anticipation of the imminent launch of Creso's first pioneering animal health product anibidiol in Switzerland and Lichtenstein as well as the upcoming launch of its human health product cannaQIX in Q1 2018, Creso is looking to aggressively expand its market reach.\nLGC brings potential access to the highest quality, competitive supply of cannabis from southern Africa, a global logistics footprint and capability to introduce Creso's innovative products to key markets of Canada and Africa and other regions within LGC's growing global footprint.\nCreso and LGC will engage in developing sales and distribution of products jointly in Europe, Canada, Latin America, Africa, Japan and the Asia-Pacific region.\nTogether, Creso and LGC will develop, produce and market innovative human and animal health solutions addressing the growing demand for cannabis and hemp-derived therapeutics, cosmetics, nutraceuticals and lifestyle products.\nThe combination of LGC's access to competitive-source cannabis with Creso's Swiss-based expertise in product development and market access is intended to deliver significant added value for customers and consumers.\nThe strategic alliance is designed to result in better access to high quality cannabis-based consumer products globally.\nDr. Miri Halperin Wernli, Co-Founder and CEO of Creso states: \"By combining our unique assets and strengths, we believe Creso and LGC will create an integrated cannabis products' opportunit...